Sylvester Homsy, MD

Sylvester Homsy, MD, is a hematology-oncologist at Atrium Health Wake Forest.

Articles by Sylvester Homsy, MD

At IVBM Charlotte 2026, Sylvester Homsy, MD, breaks down how CAR T therapies and MRD testing are reshaping multiple myeloma treatment sequencing.

Multiple Myeloma Sequencing Evolves With CAR T, MRD Insights: Sylvester Homsy, MD

April 28th 2026

CAR-T and bispecifics in multiple myeloma are reshaping sequencing, enabling earlier use, but access and standardization challenges remain, per Sylvester Homsy, MD.

Sylvester Homsy, MD

Articles by Sylvester Homsy, MD

Multiple Myeloma Sequencing Evolves With CAR T, MRD Insights: Sylvester Homsy, MD

Latest Updated Articles

Trending on AJMC

Mixed Phase 3 Results for IB6-Targeting ADC Raise Questions on Optimal Use in NSCLC

First Generic of Priftin Approved by FDA for Tuberculosis Treatment and Prevention

ATTR-CM Incidence, Prevalence Rose Sharply in the US

Switch to Ocrelizumab Shows Safety in Patients With Relapsing MS

Natera's Moshkevich Discusses TOMR Approach and the Future of MRD-Guided Care

Access, Affordability, & Accountability: A New Era in Oncology Reimbursement

Sylvester Homsy, MD

Articles by Sylvester Homsy, MD

Multiple Myeloma Sequencing Evolves With CAR T, MRD Insights: Sylvester Homsy, MD

Latest Updated Articles

Trending on AJMC

Mixed Phase 3 Results for IB6-Targeting ADC Raise Questions on Optimal Use in NSCLC

First Generic of Priftin Approved by FDA for Tuberculosis Treatment and Prevention

ATTR-CM Incidence, Prevalence Rose Sharply in the US

Switch to Ocrelizumab Shows Safety in Patients With Relapsing MS

Natera's Moshkevich Discusses TOMR Approach and the Future of MRD-Guided Care